Select Clients
The Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization of Novartis. With approximately 5,000 scientists and physicians around the world, NIBR research is focused on discovering innovative new drugs that will change the practice of medicine.
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.
Since its founding in 1947, Dana-Farber has been committed to providing cancer patients with the best treatment available today while developing tomorrow's cures through cutting-edge research.
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and 39,800 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialized Centers of Excellence.
Millipore is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing.
An early-stage biopharmaceutical company, Cequent is pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases – from inflammatory diseases to cancer – based on the company’s proprietary technology, TransKingdom RNA interference (tkRNAi). Cequent is a privately held company based in Cambridge, Massachusetts, Cequent was established in 2006.
BioScience Communications is the medical communications company for personal attention with a global reach. Bioscience Communications ensures that scientific value and messages are delivered as compelling strategies and educational programs through the hands-on dedication of senior-level staff.
Aileron Therapeutics, based in Cambridge, Massachusetts, is a biopharmaceutical company founded in 2005 to develop and advance a revolutionary class of drugs called Stapled Peptides. Aileron’s innovative and elegant peptide stabilization technology represents a breakthrough approach for modulating intracellular protein-protein interactions, critical control points for nearly all functions of a cell.
Pfizer has a leading portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas.
Vulcan creates and advances a variety of world-class endeavors and high impact initiatives that change and improve the way we live, learn, do business, and experience the world.